Clinical Trial Update: The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the safety and efficacy of lurasidone in schizophrenia patients who were switched from olanzapine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED